S.no
Author Year Country
Treatment (n)
Control (n)
Duration of treatment
Age (SD) (treatment vs. control)
Males/Females (treatment vs. control)
Stone size less than 10 mm
Mean stone size (Treatment vs. control)
1
Al-Ansari 2010 Qatar
Tamsulosin 0.4mg
Placebo
4 weeks
37.1(9.4)/36.1(9.3)
32,18/35,15
Yes
5.8(2.4)/6(2.5)
2
Aldemir 2010 Turkey Group I- Tamsulosin 0.4mg Group II- Rowatinex 100mg thrice daily
Diclofenac 100 mg
10 days
42.4(16)/46.5(1.6.5)/43.5(16.6)
22,9/17,13/19,10
Yes
6.7(1.4)/6.8(2)/6.6(1.7)
3
Alizadeh 2014 Iran
Tamsulosin 0.4 mg
No treatment
4 weeks
-
29,21/32,14
3-6 mm
-
4
Bajwa 2013 Pakistan
Tamsulosin 0.4 mg
Diclofenac 50 mg
4 weeks
32.4(8.3)/33.8(9.6)
18,12/19,11
Yes
6.9(1.4)/6.6(1.4)
5
Cervenakov 2002 Slovakia
Tamsulosin 0.4 mg
Tramadol 50 mg Diazepan and Veral 50
-
-
32,19/33,18
Yes
-
6
ElGamal 2011 Egypt
Group II Tamsulosin 0.4mg
Group I Placebo control Group III Uralyt-U Group IV Uralyt-U plus tamsulosin
4 weeks
(Tamsulosin and placebo) 35.3(5.7)/36.2(6) (Tamsulosin and placebo) 32,16/34,12
Yes
(Tamsulosin and placebo) 7.9(1.9)/7.7(1.6)
7
ElGalaly 2015 Egypt Group I Tamsulosin 0.4 mg Group II Silodosin 8mg
-
4 weeks
Tamsulosin/Silodosin 35.5(11)/33.6(9.9) Tamsulosin/Silodosin (32,19/35,17)
Yes
Tamsulosin/Silodosin (5.6(1.2)/5.4(1.5)
8
Vincendeau 2010 France
Tamsulosin 0.4 mg
Placebo
6 weeks
38.9(12)/39(11)
43,18/52,9
2-7 mm
2.9(1)/3.2(1.2)
9
Yilmaz 2004 Turkey Group II Tamsulosin 0.4mg Group III Terazosin 5mg Group IV Doxazosin 4mg
Group I No treatment
4 weeks
(Tamsulosin/control) 40.6(10),41.6(12) (Tamsulosin/control) 9,20/19,9
Yes
(Tamsulosin/control) 6(1.2)/6(1.4)
10
Aggarwal 2009 India I - Tamsulosin II – Alfuzosin III - Placeo
4 weeks
I(31.4 yrs) II(38.7 yrs) III(35.3 yrs) I(26/8) II(28/6) III(24/10)
Yes
I(6.17 mm) II(6.7mm) III(6.35 mm)
11
Ahmad 2015 Pakistan
I -Tamsulosin
II- Placebo
4 weeks
NA
4-10mm
<8mm
5.78mm
12
Cha 2012 Korea I(Tamsulosin-0.2mg OD) II(Tamsulosin - 0.2 mg BD) III(Alfuzosin) IV(Trospium)
-
4 weeks
I(45.07 yrs) II(45.5 ) III(42.33 ) IV(43.65 I(31/10) II(20/10) III(25/11) IV(18/16)
4-10mm
I(5.49mm) II(5.73mm) III(5.81mm) IV(5.59mm)
13
Dell’atti 2015 Italy I-Tamsulosin II- Silodosin
-
3 weeks
I(35 yrs) II(36 yrs) I(39/27) II(44/23)
4-10mm
I( 5.37mm) II(5.82mm)
14
Furyk 2015 Australia
I -Tamsulosin
II-Placebo
4 weeks
> 18 yrs
I(156/42) II(164/31
Yes
I(4mm) II(3.7mm)
15
Gomez 2011 Mexico
I- Tamsulosin
II-Placebo
4 weeks
I(38.5 yrs) II(38.2 yrs) I(15/17) II(21/12)
5-10mm
I(5.3mm) II(5.2mm)
16
Hermanns 2009 Switzerland
I-Tamsulosin
II-Placebo
3 weeks
I(36 yrs) II(41 yrs) I(39/6) II(36/9)
7mm or less
I(4.1mm) II(3.8mm)
17
Itoh 2013 Japan
II- Silodosin
I -Placebo
4 weeks
I(55.8 yrs) II(56.3 yrs)
all male
Yes
I(4.87mm) II(5.07mm)
18
Kumar 2015 India I- Tamsulosin II- Silodosin III- Tadalafil
-
4 weeks
I(36.4 yrs) II(36.7 yrs) III(37.5 yrs) I(62/28) II(64/26) III(67/23)
5-10mm
I(7.44mm) II(7.5mm) III(7.7mm)
19
Sameer 2014 India I-Nifedipine II- Alfuzosin
III- Control
4 weeks
I(32.74 yrs) II(30.82 yrs) III(33.06 yrs) I(19/16) II(26/9) III(23/12)
Yes
I(6.5mm) II(6.28mm) III(6.37mm)
20
Ahmad 2010 Saudi Arabia I- Tamsulosin 0.4mg II- Alfuzosin 10mg
III- control- Diclofenac 75mg
30 days
I/II/III- 40.7(14.8)/41.1(15.2)/38.9(13.3)
I/II/III- 19,10/18,12/19,09
Yes
I/II/III- 4.97(2.24)/5.47(2.13)/5.39(1.81)
21
Elsaid 2015 Egypt
Alfuzosin 5mg BD
control -Diclofenac + Hydration
4 weeks
Alfuzosin/Control- 32.8(9.5)/ 32.1(9.2)
Alfuzosin/control- 18,10/16,10
Yes
Alfuzosin/Control- 6.3(2.1)/5.9(1.9)
22
Nuraj 2017 Kosovo
I-Tamsulosin 0.4mg
Control- Diclofenac
4 weeks
Tamsulosin/Control35.5(11.0)/35.4(10.8)
Tamsulosin/Control34,18/35,17
4-10mm
Tamsulosin/Control 6.5(1.6)/6.6(1.5)
23
Pedro 2008 USA
I- Alfuzosin
Placebo
4 weeks
Alfuzosin/Placebo 36.69(13.66)/ 42.03(12.85) Alfuzosin/Placebo 28,6/27,8
Up to 8mm
Alfuzosin/Placebo- 3.83(0.94)/4.07(1.13)
24
Pickard 2015 UK I- Tamsulosin 0.4mg II- Nifedipine 30 mg
III- Placebo
4 weeks
I/II/III- 43.1(11.5)/42.3(11.0)/48.2(12.3)
I/II/III- 315,68/317,66/299,85
Yes
I/II/III- 4.6(1.6)/ 4.5(1.6)/4.5(1.7)
25
Rahman 2017 India I-Tamsulosin 0.4mg OD II- Silodosin 8 mg OD III- Silodosin 8mg + Tadalafil 5 mg
4 weeks
I/II/III- 38(10)/34(12)/ 35(10)
I/II/III- 24,16/22,18/25,15
5-10mm
I/II/III- 7.5(1.20)/7.4(1.30)/7.6(1.35)
26
Sur 2015 USA
I- Silodosin 8mg OD
II- Placebo
4 weeks
I/II- 47(13)/47(15)
I/II- 72,53/80,37
4-10mm
I/II- 5.4(1.4)/5.5(1.6)
27
Wang 2008 Taiwan I- Tamsulosin 0.4 mg OD II- Terazosin 2 mg OD
III- control
2 weeks
Tamsulosin/Terazosin/Control- 50.4(9.7)/ 51.4(8.6)/50.9(9.6)
I/II/III- 22,10/21,11/23,08
Yes
I/II/III- 6.5(1.3)/6.5(1.5)/6.5(1.4)
28
Ye 2017 Wuhan, China I- Tamsulosin 0.4mg
II- Placebo
4 weeks
I/II 40.1(11.6)/40.7(12.3) I/II- 556,1086/605,1049
Yes
I/II- 5.8(1.9)/5.7(1.8)
29
Sio 2006 Italy I- Diclofenac 100mg/day + Aescin 80mg/day II- Diclofenac 100mg + Aescin 80mg + Tamsulosin 0.4 mg
2 weeks
I/II- 44.5(11.3)/46.3(10.9)
I/II 26,20/36,14
Yes
I/II 6.4(1.3)/6.9(1.0)
30
Wang 2015 Taiwan
I- Silodosin 8mg
II- control
2 weeks
51.4(8.6)/51.5(10.5)
40,22/43,18
Yes
6.4(1.4)/6.4(1.3)
31
Yuksel 2015 Turkey
Group II Silodosin 4 mg/day
Group I Placebo
3 weeks
Placebo/Silodosin 35.23(11.20) /35.31(11.55) gp I /gp II 20,15/19,16
4-10mm
6.34(1.57)/ 6.40(1.61)
32
Porpiglia 2004 Italy Group I- Nifedipine 30 mg + Deflazacort 30 mg x 10 days + Mysoprostol 200ug Group II- Tamsulosin 0.4 mg + Deflazacort 30 mg x 10 days + Mysoprostol 200ug
Group III- no expulsive therapy given
4 weeks
Group I/II/III- 45.6 (12)/ 50.5(17)/ 42.7 (16) I/II/III- 19,11/ 18,10/ 16,12 <= 1 cm Yes I/II/III- 4.7 (1.47)/ 5.42(1.54)/ 5.35 (1.49)
33
DellaBella 2005 Italy Group I- Phloroglucinol 80 mg 3 tabs OD Group II- Tamsulosin 0.4 mg OD Group III- Nifedipine SR 30 mg OD Tab Cotrimoxazole 2 tabs OD x 8 days Tab. Deflazacort 30 mg OD x 10 days in each group
4 weeks
Group I/II/III 39.8 (12.7)/ 43.8 (13.9)/ 41.8( 15.4) I/II/III- 50/20, 54/16, 51/19
>4mm
I/II/III- 6.2 (1.7), 7.2 (2.4), 6.2 (1.5)
34
Ye 2011 China
Tamsulosin and nifedipine 3o mg
-
4 weeks
30.7(18-48)/34.5(22-50)
998,598/989,604
35
Balci 2014 Turkey
Tamsulosin and nifedipine 3o mg
4 weeks
39.5(12)/36.4(11.5)
18,7/17,8
7(1.5)/6.4(1)
36
Gandhi 2013 Nepal
Tamsulosin and nifedipine 3o mg
-
4 weeks
34(12.8)/30.4(11)
38,26/36,28
8.6(2.3)/8.9(2.5)
37
Shokeir 2016 Egypt
II-Sildenafil
I-Placebo
4 Weeks
45.3 yrs 45.8yrs
NA
Yes
NA
38
Zhang 2009 China
Tamsulosin and nifedipine 3o mg
-
4 weeks
34.6(11.4)/36.3(9.7)
63,29/68,29
Yes
6.9(1.6)/6.8(1.6)
39
Islam Bangladesh
Tamsulosin and nifedipine 2o mg
-
4 weeks
46.6/47.4
20,12/21,10
5.9(3-10)/6(3.5-10)
40
Lv 2014 China Group I - Naftopidil 50mg/day Group II- Naftopidil 50 mg/day + Celecoxib 200mg BD Group III -Celecoxib 200 mg BD
2 weeks
Group I/II/III 31.40 ± 3.94/ 33.20 ± 5.28/ 33.75 ± 5.24 Group I/II/III 20/15, 21/14, 18/15
4-9mm
I/II/III- 6.9 ± 1.30 / 7.1 ± 1.50/ 7.3 ± 1.2
41
Sun 2008 China
Group II- Naftopidil 50 mg OD
Group I - control No MET given
2 weeks
Group I/II- Control/ Naftopidil 37.8( 10.2)/ 38.2 (12.6) Control/Naftopidil- 24/6 , 26/4
-
Control/ Naftopidil- 5.7 (1.2) / 5.5 (1.2)
42
Zhou 2011 China Group I- Naftopidil 10 mg OD Group II- Tamsulosin 0.4 mg OD Group III- control no MET
2 weeks
group I/II/III- 33.73 ± 8.84/ 34.42 ± 8.64/ 34.79 ± 9.63 Group I/II/III- 25/18. 27/18, 27/16 Yes 4-9 mm Group I/II/III- 6.67 ± 0.81 6.54 ± 0.57 6.61 ± 0.74
43
Kumar 2013 India I Naftopidil II tamsulosin Prednisolone given to both groups
III control
4 weeks
33.2/33.2/33.5
-
6.9/7.1/6.6
5-10 mm
44
Kumar 2014 India I-Tamsulosin II-Tamsulosin +Tadalafil
Prednisolone given to both groups
6 Weeks
I(32.45 yrs) II(35.23 yrs) I(19/12) II(25/6)
Yes
I(7.05mm) II(6.67mm)
45
KC 2016 Nepal I-Tamsulosin II- Tadalafil
NA
2 Weeks
I(31.37 yrs) II(32.05 yrs) I(27/14) II(24/20)
Yes
I(7.09mm) II(7.13mm)
46
Puvvada 2016 India I-Tadalafil II-Tamsulosin
NA
4 Weeks
I(36.34 yrs) II(37.53 yrs) I(65/35) II(67/33)
Yes
I(7.10mm) II(7.22mm)
47
Jayant 2014 India I-Tamsulosin II- Tamsulosin+Tadalafil
NA
4 weeks
I(36.45 yrs) II(37.23 yrs) I(65/57) II(67/55)
Yes
I(6.72mm) II(7.05mm)
48
Porpiglia 2000 Italy
Group A: Deflazacort 30mg for 10 days and Nifedipine 30 mg
Group b: no treatment
4 weeks
-
26,22/24,24
5.8(18)/5.5(1.4)
< 10mm
49
Shabana 2016 Egypt Group A: Tamsulosin Group B: Tamsulosin plus methylprednisolone Group C: Alfuzosin Group D: Alfuzosin plus methylprednisolone
-
2 weeks
53/51/49/49
30,23/29,24/31,22/27,26
7.8/8.1/7.9/8
Yes
50
Borghi 1994 Italy
Nifedipine plus methylprednisolone
Placebo
45 days
-
-
6.7/6.8
Yes